學(xué)習(xí)工作經(jīng)歷 |
(1) 2010-01 至 今, 山西醫(yī)科大學(xué), 基礎(chǔ)醫(yī)學(xué)院, 教授 (2) 2004-09 至 2010-01, 山西醫(yī)科大學(xué), 基礎(chǔ)醫(yī)學(xué)院, 副教授 (3) 1999-07 至 2004-08, 山西醫(yī)科大學(xué), 基礎(chǔ)醫(yī)學(xué)院, 講師 (4) 1997-07 至 1999-06, 山西醫(yī)科大學(xué), 基礎(chǔ)醫(yī)學(xué)院, 助教 |
主持的科研 /教學(xué)項(xiàng)目 |
1. 中華人民共和國科學(xué)技術(shù)部, 國家重點(diǎn)研發(fā)計(jì)劃“常見多發(fā)病防治研究”專項(xiàng)子課題,2021YFC2501001, 食管癌變動(dòng)態(tài)演進(jìn)機(jī)制及個(gè)體化精準(zhǔn)診療體系構(gòu)建研究, 2021-12 至 2024-12, 50萬元, 在研, 主持; 2. 國家自然科學(xué)基金面上項(xiàng)目,81672768,AJUBA基因在食管癌中的作用及機(jī)制研究, 2017/01-2020/12,51萬,結(jié)題,主持; 3. 國家自然科學(xué)基金面上項(xiàng)目,81272694,ECRG2 基因在食管癌等常見惡性腫瘤中的突變、功能分析及臨床意義評(píng)價(jià), 2013/1-2016/12 ,55萬元,結(jié)題,主持; 4. 國家自然科學(xué)基金面上項(xiàng)目,81071625,食管癌相關(guān)基因2在腫瘤形成、轉(zhuǎn)移、治療中的作用及最小功能結(jié)構(gòu)域的鑒定, 2011/01-2013/12,31萬元,結(jié)題,主持; 5. 山西省強(qiáng)校工程高等學(xué)校優(yōu)秀青年學(xué)術(shù)帶頭人支持計(jì)劃,晉教科[2008]3號(hào),食管癌相關(guān)基因研究, 2009/1- 2011/12 ,20萬元,結(jié)題,主持;
|
代表性成果 (論文/專利/專著等) |
(1) Hongyi Li#, Shaojie Wang#, Xiubo Li, Yongjia Weng, Dinghe Guo, Pengzhou Kong, Caixia Cheng, Yanqiang Wang, Ling Zhang, Xiaolong Cheng*, Yongping Cui*, CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC, Cancer Science, 2023, 114(1): 91-104 (2) Fang Wang#, Caixia Cheng#, Xinhui Wang, Fei Chen, Hongyi Li, Yan Zhou, Yanqiang Wang,Xiaoling Hu, Pengzhou Kong, Ling Zhang, Xiaolong Cheng*, Yongping Cui*, Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma, Cell Death Discovery, 2022, 8(1): 182 (3) Binbin Zou#, Dinghe Guo#,Pengzhou Kong,Yanqiang Wang,Xiaolong Cheng*, Yongping Cui*, Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma, Frontiers in Molecular Biosciences, 2021, 8: 792779 (4) Hongyi Li#, Yongjia Weng#, Shaojie Wang, Fang Wang, Yanqiang Wang, Pengzhou Kong, Ling Zhang, Caixia Cheng, Heyang Cui, Enwei Xu, Shuqing Wei, Dinghe Guo, Fei Chen, Yanghui Bi, Yongsheng Meng, Xiaolong Cheng*, Yongping Cui*, CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma, Frontiers in Oncology, 2021 11:734655 (5) Xiaolong Cheng#, Shih-Hsin Lu, Yongping Cui*,ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration,Cancer Letters,2010,290(1):87-95.
|